Healthcare provider profile · identity verified

Jonathan H Bloch, D.O.

Allopathic & Osteopathic Physicians|Family Medicine · MCKINLEYVILLE, CA · NPI 1073635967

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Jonathan H Bloch, D.O. received $115.16 in general payments during 2025 across 1 reported records.

Edwards Lifesciences Corporation accounted for 100.0% of that reported general-payment amount.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$115.16

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Edwards Lifesciences Corporation	Unresolved — no canonical attribution shown	$115.16	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$115.16	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	343	94
Rosuvastatin Calcium	Rosuvastatin Calcium	329	105
Metformin Hcl	Metformin Hcl	291	73
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	243	33
Amlodipine Besylate	Amlodipine Besylate	242	78
Levothyroxine Sodium	Levothyroxine Sodium	230	45
Losartan Potassium	Losartan Potassium	214	69
Tamsulosin Hcl	Tamsulosin Hcl	213	56
Albuterol Sulfate Hfa	Albuterol Sulfate	199	54
Gabapentin	Gabapentin	199	44
Hydrochlorothiazide	Hydrochlorothiazide	188	60
Lisinopril	Lisinopril	176	41
Baclofen	Baclofen	169	76
Omeprazole	Omeprazole	164	41
Potassium Chloride	Potassium Chloride	156	36
Metoprolol Succinate	Metoprolol Succinate	153	47
Celecoxib	Celecoxib	149	65
Furosemide	Furosemide	117	31
Benazepril Hcl	Benazepril Hcl	106	26
Tizanidine Hcl	Tizanidine Hcl	104	23
Trazodone Hcl	Trazodone Hcl	94	25
Eliquis	Apixaban	88	20
Pantoprazole Sodium	Pantoprazole Sodium	87	19
Famotidine	Famotidine	86	23
Allopurinol	Allopurinol	83	21
Jardiance	Empagliflozin	77	20
Ozempic	Semaglutide	77	16
Montelukast Sodium	Montelukast Sodium	75	22
Buspirone Hcl	Buspirone Hcl	74	13
Fluticasone Propionate	Fluticasone Propionate	73	28
Simvastatin	Simvastatin	73	21
Citalopram Hbr	Citalopram Hydrobromide	72	13
Finasteride	Finasteride	72	23
Alprazolam	Alprazolam	71	16
Tramadol Hcl	Tramadol Hcl	68	15
Carvedilol	Carvedilol	63	12
Lorazepam	Lorazepam	63	12
Meloxicam	Meloxicam	63	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	15
Januvia	Sitagliptin Phosphate	60	12
Trulicity	Dulaglutide	60	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	59	12
Metoprolol Tartrate	Metoprolol Tartrate	56	17
Clopidogrel	Clopidogrel Bisulfate	53	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	21
Venlafaxine Hcl Er	Venlafaxine Hcl	51	suppressed
Bupropion Xl	Bupropion Hcl	49	14
Spironolactone	Spironolactone	49	14
Clonazepam	Clonazepam	46	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	46	suppressed
Breo Ellipta	Fluticasone/Vilanterol	45	suppressed
Duloxetine Hcl	Duloxetine Hcl	45	14
Escitalopram Oxalate	Escitalopram Oxalate	44	13
Lidocaine	Lidocaine	44	14
Mirtazapine	Mirtazapine	44	suppressed
Pregabalin	Pregabalin	44	suppressed
Morphine Sulfate Er	Morphine Sulfate	42	suppressed
Warfarin Sodium	Warfarin Sodium	42	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	40	18
Azithromycin	Azithromycin	38	37
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	29
Nystatin	Nystatin	36	12
Estradiol	Estradiol	35	11
Ondansetron Odt	Ondansetron	33	11
Bumetanide	Bumetanide	32	suppressed
Cephalexin	Cephalexin	32	30
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	31	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Xarelto	Rivaroxaban	30	11
Aripiprazole	Aripiprazole	29	suppressed
Incruse Ellipta	Umeclidinium Bromide	29	suppressed
Methenamine Hippurate	Methenamine Hippurate	29	suppressed
Digoxin	Digoxin	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	27	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Nitroglycerin	Nitroglycerin	24	16
Phenytoin Sodium Extended	Phenytoin Sodium Extended	24	suppressed
Sertraline Hcl	Sertraline Hcl	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	21
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Clotrimazole	Clotrimazole	23	11
Methadone Hcl	Methadone Hcl	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	22	suppressed
Glipizide	Glipizide	22	suppressed
Metronidazole	Metronidazole	22	15
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	18	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Methotrexate	Methotrexate Sodium	17	suppressed
Valsartan	Valsartan	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Atenolol	Atenolol	15	suppressed
Budesonide Dr	Budesonide	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Prednisone	Prednisone	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Zafirlukast	Zafirlukast	14	suppressed
Alogliptin	Alogliptin Benzoate	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Diazepam	Diazepam	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Norethindrone Acetate	Norethindrone Acetate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Verapamil Hcl	Verapamil Hcl	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Otezla	Apremilast	11	suppressed
Ramipril	Ramipril	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$115.16 · 1 records	Edwards Lifesciences Corporation	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error